Infographic: How Aware of Biosimilars are US Rheumatologists?

A recent survey of US rheumatologists found that there is room for improvement in clinicians' awareness of biosimilar therapies.

A recent survey of US rheumatologists found that there is room for improvement in clinicians' awareness of biosimilar therapies.